Cargando…
Manufacturing Bacteriophages (Part 1 of 2): Cell Line Development, Upstream, and Downstream Considerations
Within this first part of the two-part series on phage manufacturing, we will give an overview of the process leading to bacteriophages as a drug substance, before covering the formulation into a drug product in the second part. The principal goal is to provide the reader with a comprehensive framew...
Autores principales: | Tanir, Tayfun, Orellana, Marvin, Escalante, Aster, Moraes de Souza, Carolina, Koeris, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471501/ https://www.ncbi.nlm.nih.gov/pubmed/34577634 http://dx.doi.org/10.3390/ph14090934 |
Ejemplares similares
-
Manufacturing Bacteriophages (Part 2 of 2): Formulation, Analytics and Quality Control Considerations
por: Moraes de Souza, Carolina, et al.
Publicado: (2021) -
Upstream AUGs and upstream ORFs can regulate the downstream ORF in Plasmodium falciparum
por: Kumar, Mayank, et al.
Publicado: (2015) -
Upstream plasticity and downstream robustness in evolution of molecular networks
por: Maslov, Sergei, et al.
Publicado: (2004) -
Downstream EWS/FLI1 - upstream Ewing's sarcoma
por: Kovar, Heinrich
Publicado: (2010) -
Upstream and Downstream of Recombinants Biomolecules to Health Care Industry
por: Mazzola, Priscila G., et al.
Publicado: (2016)